Top Markets
Coin of the day
Merrimack Pharmaceuticals, Inc. Merrimack Pharmaceuticals, Inc.

Merrimack Pharmaceuticals, Inc.

MACK
Rank in Stocks #18348
Founded in 1993, Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company... Founded in 1993, Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts.
Share Price
$15.13
Last synced: 2024-05-28
Market Cap
$202.89M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Merrimack Pharmaceuticals, Inc. (MACK)

Category

P/E ratio for Merrimack Pharmaceuticals, Inc. (MACK)
P/E ratio as of September 2026 TTM: -183.35
According to Merrimack Pharmaceuticals, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -183.35. At the end of 2022 the company had a P/E ratio of -100.38.
P/E ratio history for Merrimack Pharmaceuticals, Inc. from 2009 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) -183.35 12.93%
2023 -162.36 61.75%
2022 -100.38 370.09%
2021 -21.35 -29.86%
2020 -30.45 1,439.35%
2019 -1.98 97.50%
2018 -1.00 -543.29%
2017 0.23 -108.52%
2016 -2.65 -43.33%
2015 -4.68 -58.02%
2014 -11.15 251.73%
2013 -3.17 -17.13%
2012 -3.82 448.74%
2011 -0.70 -35.23%
2010 -1.08 -2.06%
2009 -1.10 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
31.44 -117.15%
US
36.85 -120.10%
NL
-17.59 -90.41%
US
-23.32 -87.28%
AU
- -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.